Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Polyunsaturated Fatty Acids in Child Nutrition (PINGU)

5 novembre 2014 mis à jour par: Research Institute of Child Nutrition, Dortmund

Polyunsaturated Fatty Acids in Child Nutrition - A German Multimodal Optimisation Study

Primary objective of this study is to examine the effects of 2 different approaches of dietary strategies to optimise fatty acid composition in complementary food on infant's fatty acid status and its consequences on cognitive and visual development.

Subjects are randomly assigned to one of three groups:

  • Rapeseed oil (high in n-3 PUFA and small n-6:n-3 ratio to support endogenous n- 3 LC-PUFA metabolism)
  • Fatty fish (preformed n-3 LC-PUFA, especially DHA)
  • Corn oil (as control group, high in n-6 PUFA, common in complementary food).

The intervention starts with the beginning of complementary feeding as generally recommended between 4 to 6 months of age and ends at the age of 10 months. For this period of time subjects of all groups receive commercial vegetable-potato-meat-meals as part of complementary food which only differs in the fatty acid composition.

Aperçu de l'étude

Statut

Complété

Les conditions

Description détaillée

A well balanced supply of polyunsaturated fatty acids, in particular the omega-3 long chain docosahexaenoic acid (DHA), in early childhood is essential for children's cognitive and visual development. DHA can either be supplied preformed in the diet (e.g. via fatty fish) or synthesised by conversion of its essential precursor alpha-linolenic acid (e.g. via rapeseed oil). The study examines the effect of two different approaches to optimise infants´ fatty acid status.

The study sample consists of healthy newborns and their mothers (3 x 57 infants according to a priori power calculation) who are enrolled in delivery hospitals in the region of Dortmund, Germany. In total, the individual study program covers the first 10 months of infant's life. Biomarkers of fatty acid status from the mother are collected 8 weeks pp for the estimation of pre- and perinatal fatty acid supply. Additionally, information on maternal diet during pregnancy and after delivery is assessed. The intervention covers the period of complementary feeding (from 4 to 6 months of age until 10 months of age). In all groups the specific study food is given 5 to 7 times a week, whereas 2 of these are fish meals in the fatty fish group. At the age of 4 and 10 months blood samples are collected from the infants to examine the effect on blood fatty acid status. Parameters of visual and cognitive development are also assessed at the age of 4 and 10 months using VEP examinations and Bayley scales. Infants´ dietary intake is assessed from the end of the 2 months until 10 months of age using continuous weighed dietary records.

Type d'étude

Interventionnel

Inscription (Réel)

214

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Dortmund, Allemagne, 44225
        • Research Institute of Child Nutrition

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

Pas plus vieux que 1 mois (Enfant)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • a term healthy newborn infant ( birth weight > 2500 g, gestational age > 37 weeks
  • German speaking mother
  • the intention of the mother to breast-feed the children and to feed study menus at least 5 times per week beginning in the fifth to seventh month of life.

Exclusion Criteria:

  • preterm children
  • twins

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Quadruple

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Rapeseed oil
Study group receive commercial vegetable-potato-meat-meals containing rapeseed oil as part of complementary food
Groups receive commercial vegetable-potato-meat-meals as part of complementary food which differs in the fatty acid composition
Expérimental: Fatty fish
Study group receive 2 times per week a vegetable-potato-meat-meals as part of complementary food.
Groups receive commercial vegetable-potato-meat-meals as part of complementary food which differs in the fatty acid composition
Comparateur actif: Corn oil
Study group receive commercial vegetable-potato-meat-meals containing corn oil as part of complementary food
Groups receive commercial vegetable-potato-meat-meals as part of complementary food which differs in the fatty acid composition

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Infants´ fatty acid status
Délai: 10 months after delivery
Fatty acids (saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids including long-chain polyunsaturated fatty acids) are measured in percent of total fatty acids in erythrocyte membranes, whole plasma, and cheek cells in order to assess the fatty acid composition.
10 months after delivery

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Infants´ visual development
Délai: 10 months after delivery
Infants´ visual development is assessed using the visual evoked potentials method.
10 months after delivery
Infants´ cognitive development
Délai: 10 months after delivery
Infants´ cognitive development is assessed using the Bayley II scale.
10 months after delivery
Infants´ haemogram
Délai: 10 months after delivery
10 months after delivery
Infants´antioxidant status
Délai: 10 months after delivery
10 months after delivery
Infants´ body weight
Délai: 10 months after delivery
10 months after delivery
Infants´ dietary intake
Délai: from 2 until 10 months after delivery
from 2 until 10 months after delivery
Maternal dietary intake
Délai: pregnancy and first 2 months post partum
pregnancy and first 2 months post partum
Infant's preference for fish
Délai: 10 month after delivery
10 month after delivery
Infant's preference for new flavour
Délai: 10 month after delivery
10 month after delivery
Parental attitudes about fish and feeding strategies
Délai: 10 months after delivery
10 months after delivery
Mother´s fatty acid status
Délai: 2 months after delivery
Fatty acids (saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids including long-chain polyunsaturated fatty acids) are measured in percent of total fatty acids in erythrocyte membranes, whole plasma, cheek cells, and breast milk in order to assess the fatty acid composition.
2 months after delivery
Infants´ body length
Délai: 10 months after delivery
10 months after delivery
Infant´s head circumference
Délai: 10 months after delivery
10 months after delivery

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: Mathilde Kersting, Professor, Research Institute of Child Nutrition

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 avril 2011

Achèvement primaire (Réel)

1 septembre 2013

Achèvement de l'étude (Réel)

1 septembre 2013

Dates d'inscription aux études

Première soumission

15 septembre 2011

Première soumission répondant aux critères de contrôle qualité

6 décembre 2011

Première publication (Estimation)

8 décembre 2011

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

6 novembre 2014

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 novembre 2014

Dernière vérification

1 novembre 2014

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • PINGU0911DO

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

3
S'abonner